![](https://news.europawire.eu/wp-content/uploads/2022/03/GSK-ANEMIA-144x144.jpg)
Submission for the treatment of anaemia of chronic kidney disease based on the ASCEND Phase III clinical trial programme, consisting of five trials that all met their co-primary efficacy and safety endpoints EMA file acceptance is the first major regulatory … Read the full press release